LicianPro

PTC THERAPEUTICS, INC. ·

PTCT 8-K 2026-09-21

PTC THERAPEUTICS, INC. (PTCT) 8-K dated 2026-09-21 — accession 0001070081-26-000023.

PTC THERAPEUTICS, INC. (PTCT) is a biotechnology company listed on NASDAQ.

PTC THERAPEUTICS, INC. filed a 8-K on 2026-09-21. Accession 0001070081-26-000023.

This 8-K covers: Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PTCT revenue for 2025-12-31 was $1.73B. Net income was $682.6M. Revenue was up 114.5% from 2024-12-31 to 2025-12-31. PTCT currently screens at market cap $6.51B.

Not investment advice. The PTCT SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr